A prominent biotech developer is taking the reins of a long-awaited Silicon Valley mixed-use campus project, a deal that will not only bulk up its own expanding life science portfolio but also underscore persistent demand for research and development space in the nation's second-largest biotech market.
Biotech Developer Extends Office Acquisition Streak With Purchase of Bay Area Development Site
IQHQ Closes on Silicon Valley’s Elco Yards To Develop Into Future Mixed-Use Life Science Campus
By Katie Burke
CoStar News
November 1, 2021 | 8:00 P.M.
This news story is available exclusively to CoStar subscribers.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In